Published in Clin Pharmacol Ther on April 01, 1996
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol (2007) 1.14
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Analysis of flanking sequences from dissociation insertion lines: a database for reverse genetics in Arabidopsis. Plant Cell (1999) 3.65
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Application of a weighted head-banging algorithm to mortality data maps. Stat Med (1999) 2.55
The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol (1992) 2.52
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Passive smoking and lung cancer. Lancet (1983) 2.27
Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation (1996) 2.13
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics (1985) 1.92
Drug-induced QT prolongation in women during the menstrual cycle. JAMA (2001) 1.87
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Study on the inhibitory effect of tannins and flavonoids against the 1,1-diphenyl-2 picrylhydrazyl radical. Biochem Pharmacol (1998) 1.81
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J (1995) 1.76
Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J (1986) 1.74
Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model. J Cardiovasc Electrophysiol (1997) 1.74
Ethylene provides positional information on cortical cell division but is not involved in Nod factor-induced root hair tip growth in Rhizobium-legume interaction. Development (1997) 1.69
Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther (1992) 1.68
Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol (1984) 1.67
Cis- and trans-acting factors regulating transcription of the BGT1 gene in response to hypertonicity. Am J Physiol (1998) 1.66
Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging (2006) 1.58
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
A rapid cold-hardening process in insects. Science (1987) 1.55
Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology (2005) 1.54
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol (1988) 1.54
RNA polymerase I can mediate expression of CAT and neo protein-coding genes in Trypanosoma brucei. EMBO J (1991) 1.53
Cardiac actions of erythromycin: influence of female sex. JAMA (1998) 1.53
Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis (2001) 1.51
Postoperative hyponatremia. A prospective study. Arch Intern Med (1986) 1.50
Social context and geographic patterns of homicide among US black and white males. Am J Public Health (2000) 1.46
Comparison of the proportionate mortality ratio and standardized mortality ratio risk measures. Am J Epidemiol (1980) 1.44
SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol Aging (2007) 1.42
Pharmacies and prevention of potentially fatal drug interactions. JAMA (1996) 1.42
Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther (1995) 1.40
Limb defects after chorionic villus sampling. Obstet Gynecol (1995) 1.40
Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface. Food Drug Law J (1998) 1.39
Sensitivity and specificity-like measures of the validity of a diagnostic test that are corrected for chance agreement. Epidemiology (1992) 1.39
Peritoneal-uterine communication: a complication of prolonged embedding of a peritoneal catheter. Perit Dial Int (2012) 1.38
Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther (1998) 1.38
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther (1995) 1.31
Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmacogenetics (1995) 1.31
Information available from surrogate respondents in case-control interview studies. Am J Epidemiol (1983) 1.31
Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril (2000) 1.30
Thyroid cancer in Connecticut, 1935-1975: an analysis by cell type. Am J Epidemiol (1980) 1.29
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol (1981) 1.28
Developmental aspects of the Rhizobium-legume symbiosis. Plant Mol Biol (1992) 1.26
Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation (2000) 1.23
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation (1987) 1.22
Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health (1998) 1.21
Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events. Mol Cell Biol (1991) 1.19
Drug therapy. Flecainide. N Engl J Med (1986) 1.19
Discovery and characterization of a new transposable element, Tn4811, in Streptomyces lividans 66. J Bacteriol (1992) 1.16
Diet in the etiology of oral and pharyngeal cancer among women from the southern United States. Cancer Res (1984) 1.16
Chlorpheniramine plasma concentration and histamine H1-receptor occupancy. Clin Pharmacol Ther (1995) 1.15
Nitric oxide mediated venodilator effects of nebivolol. Br J Clin Pharmacol (1994) 1.13
Rapid diagnosis of alpha-thalassemia-1 of southeast Asia type and hydrops fetalis by polymerase chain reaction. Blood (1991) 1.12
Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst (1985) 1.12
Intracranial metastases in the initial staging of bronchogenic carcinoma. Chest (1984) 1.11
Lindane toxicity and protein-deficient diet. Arch Environ Health (1968) 1.11
Greater quinidine-induced QTc interval prolongation in women. Clin Pharmacol Ther (2000) 1.11
Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res (2001) 1.10
Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant (1999) 1.10
Pregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril (2000) 1.09
VsENOD5, VsENOD12 and VsENOD40 expression during Rhizobium-induced nodule formation on Vicia sativa roots. Plant Mol Biol (1995) 1.08
An example of sample size determination for family studies. Am J Epidemiol (1981) 1.08
The clinical value of FDA class C drugs approved from 1981 to 1988. Clin Pharmacol Ther (1992) 1.07
Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6. Clin Pharmacol Ther (1993) 1.07
Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response relations. Am J Cardiol (1984) 1.07
Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology (1983) 1.06
A case of intraperitoneal fracture of a double-cuff Tenckhoff catheter. Perit Dial Int (2014) 1.06
Suppression of ventricular ectopic depolarizations by tocainide. Circulation (1977) 1.06
Antimicrobial activity of tannin components from Vaccinium vitis-idaea L. J Pharm Pharmacol (2001) 1.06
Sequential pituitary MR imaging in Sheehan syndrome: report of 2 cases. AJNR Am J Neuroradiol (2008) 1.05
Tuberculosis in maintenance dialysis patients. Nephron (2001) 1.05
Pregnancy and delivery of healthy infants developed from vitrified blastocysts in an IVF-ET program. Fertil Steril (2000) 1.05
Suppression of chronic ventricular arrhythmias with propranolol. Circulation (1979) 1.04
Identification of differentially expressed genes in normal mucosa, adenoma and adenocarcinoma of colon by SSH. World J Gastroenterol (2001) 1.04
Stereoselective disposition and pharmacologic activity of propafenone enantiomers. Circulation (1989) 1.04
Lung cancer in Louisiana: death certificate analysis. J Natl Cancer Inst (1979) 1.03
Descending mesocolon defect herniation: case report. Changgeng Yi Xue Za Zhi (1999) 1.03
Effect of cobalt on synthesis and activation of Bacillus licheniformis alkaline phosphatase. J Bacteriol (1981) 1.02
Biological sex analysis in clinical research. J Womens Health Gend Based Med (2000) 1.02
Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int (1985) 1.02
Lanthanum carbonate (Fosrenol) efficacy and tolerability in the treatment of hyperphosphatemic patients with end-stage renal disease. Clin Nephrol (2005) 1.02
A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2007) 1.02
Influence of genetic polymorphism on the metabolism and disposition of encainide in man. J Pharmacol Exp Ther (1984) 1.02
Inhibition of nitric oxide release by an aqueous extract of Tinospora tuberculata. Phytother Res (2000) 1.01
Primary pontine hemorrhage and the dysarthria-clumsy hand syndrome. Neurology (1982) 1.01
More evidence supports the association of PPP3CC with schizophrenia. Mol Psychiatry (2007) 1.01
Patient delay in the diagnosis of cancer, emphasizing malignant melanoma of the skin. Prog Clin Biol Res (1982) 1.01
Normal distribution of acetylation phenotypes in systemic lupus erythematosus. Arthritis Rheum (1978) 1.00
Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. Clin Pharmacol Ther (2009) 1.00
Mechanism of cardiotoxicity of halofantrine. Clin Pharmacol Ther (2000) 1.00
Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer (1988) 1.00
Cytogenetic and molecular characterization of marker chromosomes in patients with mosaic 45,X karyotypes. Hum Genet (1992) 1.00
Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant (1991) 1.00
Lung cancer in motor exhaust-related occupations. Am J Ind Med (1989) 1.00